Author/Authors :
Basnet, Sijan Department of Medicine - Reading Health System, West Reading, PA, USA , Tachamo, Niranjan Department of Medicine - Reading Health System, West Reading, PA, USA , Tharu, Biswaraj Tribhuvan University - Maharajgunj Medical Campus, Kathmandu, Nepal , Dhital, Rashmi Universal College of Medical Sciences - Tribhuvan University, Bhairahawa, Nepal , Ghimire, Sushil Department of Medicine - Reading Health System, West Reading, PA, USA , Ram Poudel, Dilli Department of Medicine - Reading Health System, West Reading, PA, USA
Abstract :
Rivaroxaban is a novel oral anticoagulant used in the treatment of venous thromboembolism. The use of this medication has
expanded over the recent years with resultant expansion of side effect profile. We present a case of a 56-year-old female who
presented with shortness of breath and chest pain 12 weeks after starting rivaroxaban for left upper extremity deep vein thrombosis.
She was later diagnosed with spontaneous hemopericardium requiring pericardial fluid drainage. Rarer side effects like this will
be encountered more often with the increasing use of novel oral anticoagulants. The clinicians should be cognizant of this entity
among patients with shortness of breath and chest pain for timely diagnosis and intervention.
